Effect of plasma from patients with Behçet's disease on the production of nitric oxide in cultured human umbilical vein endothelial cells

Medical Principles and Practice

Volumn 13, Issue 1, 2004, Pages 35-38

  Örem, Asim ^a,c   Ertürk, Murat ^a   Çimşit, Gülseren ^b   Kural, Birgül Vanizor ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^c KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; Human umbilical vein endothelial cells; Nitric oxide

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; COLCHICINE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BEHCET DISEASE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ACTIVITY; ENDOTHELIUM CELL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKOCYTE COUNT; MALE; NEUTROPHIL; PLASMA; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHCET SYNDROME; CELLS, CULTURED; COLCHICINE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PLASMA; UMBILICAL VEINS;

EID: 0345600138     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074049     Document Type: Article

References (21)

1. Behçet H: Über rezidivierende Aphthose: Durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 1937;105:1152.
2. Samlaska CP, James WD: Superficial thrombophlebitis. II. Secondary hypercoagulable states. J Am Acad Dermatol 1990;23:1-18.
3. Hampton KK, Chamberlain MA, Menon DK, Davies JA: Coagulation and fibrinolytic activity in Behçet's disease. Thromb Haemost 1991;66:292-294.
4. Schmitz-Huebner U, Knop J: Evidence for endothelial cell dysfunction in associated with Behçet's disease. Thromb Res 1984;34:277-285.
5. Lincoln J, Hoyle CHV, Burnstock G (eds): Nitric Oxide in Healthy and Disease. Cambridge, Cambridge University Press, 1997, pp 27-41.
6. Farrell AJ, Blake DR: Nitric oxide. Ann Rheum Dis 1996;55:7-20.
7. Liao JK, Shin WS, Lee WY, Clark SL: Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995;270:319-324.
8. Örem A, Vanizor B, Çim̧it G, Kiran E, Deger O, Malkoç M: Decreased nitric oxide production in patients with Behçet's disease. Dermatology 1999;198:33-36.
9. International Study Group for Behçet's Disease: Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-1080.
10. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2245-2756.
11. Ibrahim AS: Personal communication. Harbor-UCLA Research and Education Institute, Torrance, Calif., USA. Ibrahim@afp76.humc.edu.
12. Bradford MM: A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Ann Biochem 1976;72:248-254.
13. Devidge ST, Baker PN, Roberts JM: NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am J Physiol Heart Circ Physiol 1995;38:H1106-H1112.
14. Ding Y, Vaziri ND: Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension 1998;32:718-723.
15. Haznedaroglu IC, Ozcebe OI, Ozdemir O, Celik I, Dundar SV, Kirazli S: Impaired haemostatic kinetics and endothelial function in Behçet's disease. J Intern Med 1996;240:181-187.
16. Direskeneli H, Keser G, D'Cruz D, Khamashta MA, Akoglu T, Yazici H, Yurdakul S, Hamuryudan V, Ozgun S, Goral AJ: Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behcet's disease. Clin Rheumatol 1995;14:55-61.
17. Yoshida T, Tanaka M, Sotomatsu A, Okamoto K, Hirai S: Serum of Behçet's disease enhances superoxide production of normal neutrophils. Free Radic Res 1998;28:39-44.
18. Dogan P, Tanrikulu G, Soyuer U, Kose K: Oxidative enzymes of polymorphonuclear leucocytes and plasma fibrinogen, ceruloplasmin, and copper levels in Behçet's disease. Clin Biochem 1994;27:413-418.
19. Örem A, Efe H, Deger O, Çimşit G, Uydu HA, Vanizor B: Relationship between lipid peroxidation and disease activity in patients with Behçet's disease. J Dermatol Sci 1997;16:11-16.
20. Örem A, Çimşit G, Deger O, Vanizor B, Karahan SC: Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease. Dermatology 1999;198:243-246.
21. Li H, Forstermann U: Nitric oxide in the pathogenesis of vascular disease. J Pathol 2000; 190:244-254.